The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Management of Hereditary Hemochromatosis in Pregnancy

In pregnant women carrying HFE mutations, the balance between iron load and fetal health is carefully maintained.

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Kadın Hastalıkları ve Doğum department. Book Appointment →

What is Management of Hereditary Hemochromatosis in Pregnancy?

Pregnancy creates a natural 'phlebotomy' effect due to plasma volume expansion and fetal-placental iron requirements; this may reduce iron load in women with hereditary hemochromatosis. However, in some patients, history of liver fibrosis and cardiomyopathy poses additional risks during pregnancy.

Diagnosis is made with transferrin saturation, ferritin, HFE gene analysis, and hepatic MRI T2* when needed. Routine phlebotomy or chelation therapy is generally not required in pregnancy; case-based evaluation is made in advanced load with very high ferritin.

Maternal management includes liver function tests, echocardiography, and glycemic monitoring. In the postpartum period, the phlebotomy protocol is reorganized, and HFE genotype analysis of the newborn may be planned.

Symptoms

Fatigue and weakness
Joint pain
Increased skin pigmentation
Elevated liver enzymes
Findings of arrhythmia or heart failure
Diabetes-like glycemic disturbance

Risk Factors

HFE C282Y homozygous
Compound heterozygous (C282Y/H63D)
Family history of hemochromatosis
Previous liver fibrosis
Past cardiomyopathy
Confirmed iron overload

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • For preconception iron load evaluation
  • Increased weakness and joint pain
  • Elevation of liver enzymes
  • Development of arrhythmia or shortness of breath

Treatment Methods

01
Genetic counseling and HFE gene analysis
02
Transferrin saturation and ferritin monitoring
03
Liver function and echocardiography monitoring
04
Careful phlebotomy when needed
05
Glycemic monitoring
06
Replanning of the postpartum phlebotomy protocol

Which Department to Visit?

You can visit our Kadın Hastalıkları ve Doğum department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Kadın Hastalıkları ve Doğum Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Regular Gynecological Check-up

Kadın Hastalıkları ve Doğum

Regular gynecological check-ups enable early diagnosis of many women's diseases and increase treatment success. It is recommended that every sexually active woman or woman over 21 see a gynecologist at least once a year.

Cervical Cancer

Kadın Hastalıkları ve Doğum

Cervical cancer develops from uncontrolled growth of cells in the cervix and is among the most common women's cancers worldwide. Precancerous lesions can be recognized with regular Pap smear and HPV testing.

HPV and Vaccination

Kadın Hastalıkları ve Doğum

HPV is a common virus transmitted sexually that can lead to certain types of cancer. Vaccination provides over 90% protection against high-risk HPV strains.

Ovarian Cyst

Kadın Hastalıkları ve Doğum

Ovarian cysts are fluid-filled sacs that form in or on the ovarian tissue. Most are asymptomatic and disappear spontaneously; however, large or complex cysts can cause pain and complications.

Endometriosis

Kadın Hastalıkları ve Doğum

Endometriosis affects about 10% of women of reproductive age, causing cyclic pelvic pain, dysmenorrhea, dyspareunia, and infertility; combined medical and laparoscopic treatment improves quality of life.

Uterine Fibroids

Kadın Hastalıkları ve Doğum

Uterine fibroids are benign tumors developing from the uterine muscle layer. They affect 20-50% of women of reproductive age; most are asymptomatic, but can cause bleeding and pain.

Polycystic Ovary Syndrome (PCOS)

Kadın Hastalıkları ve Doğum

PCOS is the most common endocrine disease affecting approximately 10% of women of reproductive age, characterized by androgen excess, ovulation disorder, and polycystic ovarian appearance.

Menopause

Kadın Hastalıkları ve Doğum

Menopause is the life stage defined by not having a period for 12 consecutive months and the natural cessation of ovarian function. The average age is 51, but it can vary between 45-55 years.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.